OMRON Healthcare Co., Ltd.
OMRON
OMRON Healthcare is the world's leading manufacturer of home blood pressure monitors and cardiovascular diagnostic devices, founded in 1933 in Kyoto, Japan. With healthcare annual revenue of ¥145.9 billion, the company operates 5+ manufacturing facilities across Japan, China, and Vietnam. OMRON is virtually synonymous with home blood pressure monitoring, selling in over 110 countries worldwide.
Strengths: Unmatched brand recognition as the #1 doctor-recommended blood pressure monitor brand worldwide; proprietary AI-powered AFib detection technology integrated into consumer devices; diversified home healthcare portfolio spanning 4.1 (BP monitors), 4.4 (nebulizers), 4.5 (thermometers); strong multi-country manufacturing resilience.
Weaknesses: Revenue declined due to global consumer spending pressure; healthcare segment represents only a fraction of total OMRON group revenue; relatively lower growth rate compared to digital health pure-plays.Read MoreShow Less
Strengths: Unmatched brand recognition as the #1 doctor-recommended blood pressure monitor brand worldwide; proprietary AI-powered AFib detection technology integrated into consumer devices; diversified home healthcare portfolio spanning 4.1 (BP monitors), 4.4 (nebulizers), 4.5 (thermometers); strong multi-country manufacturing resilience.
Weaknesses: Revenue declined due to global consumer spending pressure; healthcare segment represents only a fraction of total OMRON group revenue; relatively lower growth rate compared to digital health pure-plays.
In the press
All coverage →5 latest headlines- Shaping the Future Together: OMRON’s Commitment to Creating Value in India - OMRON Globalwww.omron.com2026-10-20
- Weekly Recap: Omron Robotics–Comau cooperation and VIVA 360+ U.S. launch - TradingViewwww.tradingview.com2026-10-19
- OMRON Healthcare Launches VIVA 360+ Full-Body Smart Scale in the U.S. - Yahoo Financefinance.yahoo.com2026-10-14
- OMRON Healthcare Marks 40 Years of Ohasama Study for World Heart Day - The Globe and Mailwww.theglobeandmail.com2026-09-15
- Omron and UCSF launch randomised trial assessing early AF detection via at-home blood pressure monitoring - Cardiac Rhythm Newscardiacrhythmnews.com2026-04-07
• Automatic upper-arm and wrist blood pressure monitors with IntelliWrap technology
• AI-powered AFib atrial fibrillation detection integrated into standard BP cuffs
• Nebulizers for asthma and respiratory condition home treatment
• Infrared ear and forehead thermometers with clinical accuracy
• Electrode placement and ECG monitoring accessories
• Healthcare cloud services for data tracking and physician sharing
Quick Facts
Headquarters
Kyoto, Japan
Founded
1933
Employees
15000+
Revenue
¥146 B
Factories
5+ factories in Japan, China, Vietnam
Presence
110+ Countries
Listing
Public (TYO: 6645)
Categories
Related
Similar listed companies
- Apple Inc.· $5 T
- Amazon.com, Inc.· $2.7 T
- Samsung Electronics Co., Ltd.· $1.1 T
- Johnson & Johnson (J&J)· $616 B
- Allergan Aesthetics· $504 B
- Cisco· $423 B
Data Sources & Methodology
This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.
VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.
Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.
Key references: Official Website Public (TYO: 6645) , Data Sources & Methodology
Omron Official Website
Omron 50M Nebulizers Milestone
Omron CEO Message - Integrated Report 2025
Omron - Wikipedia